| |
| |
|
| Insider
Information: |
Gergel Ivan |
| Relationship: |
SVP & Chief Medical Of... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
56,553 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$71,822 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,553 |
|
|
| Total
Value |
$71,822 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endo Health Solutions Inc |
ENDP |
EVP, R&D and CSO |
2014-02-28 |
0 |
2009-02-26 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
SVP & Chief Medical Of... |
2017-11-16 |
56,553 |
2016-02-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-07-18 |
4 |
OE |
$11.04 |
$606,317 |
D/D |
54,920 |
98,492 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-10-02 |
4 |
OE |
$11.04 |
$626,012 |
D/D |
56,704 |
98,279 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-09-29 |
4 |
OE |
$11.04 |
$477,988 |
D/D |
43,296 |
84,871 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-07-12 |
4 |
OE |
$11.04 |
$405,069 |
D/D |
36,691 |
80,263 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
• – – |
2013-04-24 |
4 |
OE |
$19.93 |
$2,181,471 |
D/D |
105,190 |
64,519 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
61,575 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-11-16 |
4 |
D |
$44.23 |
$222,123 |
D/D |
(5,022) |
56,553 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
• – – |
2010-12-03 |
4 |
OE |
$19.93 |
$1,235,418 |
D/D |
55,603 |
55,603 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-07-11 |
4 |
OE |
$11.04 |
$92,615 |
D/D |
8,389 |
51,961 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
• – – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,690 |
51,399 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2016-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
46,479 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-02-16 |
4 |
S |
$13.14 |
$19,145 |
D/D |
(1,457) |
45,022 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-05-16 |
4 |
S |
$19.55 |
$28,348 |
D/D |
(1,450) |
43,572 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-07-11 |
4 |
AS |
$21.04 |
$176,505 |
D/D |
(8,389) |
43,572 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-07-12 |
4 |
AS |
$21.09 |
$773,813 |
D/D |
(36,691) |
43,572 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-07-18 |
4 |
AS |
$21.10 |
$1,158,812 |
D/D |
(54,920) |
43,572 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
• – – |
2013-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,952 |
42,709 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-08-16 |
4 |
S |
$19.32 |
$38,582 |
D/D |
(1,997) |
41,575 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-09-29 |
4 |
AS |
$24.04 |
$1,040,836 |
D/D |
(43,296) |
41,575 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2017-10-02 |
4 |
AS |
$24.21 |
$1,372,804 |
D/D |
(56,704) |
41,575 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
• – – |
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,658 |
35,669 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
• – – |
2012-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,271 |
33,271 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
• – – |
2011-02-28 |
4 |
OE |
$19.93 |
$609,918 |
D/D |
30,603 |
30,603 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
• – – |
2014-02-27 |
4 |
D |
$79.82 |
$72,556 |
D/D |
(909) |
27,649 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
• – – |
2016-08-16 |
4 |
S |
$17.56 |
$29,589 |
D/D |
(1,685) |
27,327 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
